Pipeline Phase Listing Configuration


Therapetic Area : bms:therapeutiic-area/hematology

Tumor : bms:tumor/myelofibrosis

Brand Compound Name :

INREBIC®
(fedratinib)

Pipeline Phase Listing Content

Researches and their phases:::

Phase:
bms:phase/phase-3

Research Area/Line of Therapy

Previously treated with Ruxolitinib